PT-141
How to reconstitute the 10 mg vial and convert any target dose into insulin units. PT-141 is the prescription drug Vyleesi (bremelanotide); its FDA label dose is 1.75 mg subcutaneous, as needed, max 1/24 h and 8/month. Reconstitution math is shown for the 5 mg and 10 mg research vials.
Calculate for your vial
Enter the mg on your PT-141 vial, the bacteriostatic water you added, and your target dose — it works out the exact units to draw on a U-100 insulin syringe, for whatever you personally have.
Reconstitution Calculator
Check the decimal. A misplaced decimal point here is a 10× dosing error. Re-read every number, and confirm your dose with a licensed clinician before you draw.
Educational only — not a dosing recommendation. This tool does the measurement math; it does not tell you what to take. On a U-100 insulin syringe, 100 units = 1 mL.
1 · Find your dose
Pick what you're using PT-141 for and how much bacteriostatic water you added — this pulls out the exact units to draw and how often people report using it.
to draw 1.75 mg–1.75 mg at 1 mL water
10 mg/mL · 100 mcg per unit
- How often
- As needed · no more than 1 dose per 24 h
- Cycle
- No more than 8 doses per month (label limit)
2 · Reconstitute it cleanly, step by step
How to turn the 10 mg powder into a measured liquid with clean, sterile technique. More water means each insulin unit holds less peptide — easier to measure small amounts accurately.
1Swab the stoppers
Wipe the rubber top of each vial with an alcohol pad and let it air-dry.
2Draw the water
Pull your bacteriostatic water up into the insulin syringe.
3Reconstitute
Inject it slowly down the inside wall of the peptide vial — never straight onto the powder.
4Swirl to dissolve
Gently swirl until the powder fully dissolves into a clear liquid. Never shake.
5Equalize, then draw
To draw a dose: push in an equal amount of air first to equalize the pressure, then pull your dose.
- 1
Swab both tops
Wipe the rubber top of the bacteriostatic-water vial and the PT-141 vial stopper with a fresh alcohol pad, and let them air-dry. Never touch the needle or the stoppers after wiping.
Alcohol swab · let dry - 2
Draw the water
First pull 1 mL of air into the syringe and inject it into the bacteriostatic-water vial to equalize the pressure, then draw your 1 mL of water back out. Inject it into the PT-141 vial down the inside glass wall, not onto the powder.
1 mL BAC water - 3
Swirl, don't shake
Gently swirl the 10 mg vial until the powder fully dissolves into a clear liquid. Never shake — shaking can damage the peptide and foam the solution.
Swirl, don't shake - 4
Know your strength
The vial is now 10 mg/mL. Each unit on a U-100 syringe holds about 100 mcg.
10 mg/mL - 5
Re-swab & draw your dose
Wipe the stopper again. With a fresh insulin syringe, pull back 15 units of air and inject it into the vial to equalize the pressure, then draw 15 units (0.15 mL) for a 1.5 mg dose.
15 units - 6
Store it right
Keep the mixed vial in the fridge, away from light. Use a new sterile syringe every time, never share, and drop used sharps in a proper container.
Refrigerate · fresh needle
What each water volume gives you:
3 · Full units reference
Every bacteriostatic-water volume (rows) against every target dose (columns) — each cell is the U-100 units and the exact draw in mL. The highlighted row is the easiest volume to measure.
| BAC water | Concentration | Per unit | 1 mg | 1.5 mg | 1.75 mg |
|---|---|---|---|---|---|
| 1 mLeasy pick | 10 mg/mL | 100 mcg | 10u0.1 mL | 15u0.15 mL | 17.5u0.175 mL |
| 2 mL | 5 mg/mL | 50 mcg | 20u0.2 mL | 30u0.3 mL | 35u0.35 mL |
| 3 mL | 3.33 mg/mL | 33.33 mcg | 30u0.3 mL | 45u0.45 mL | 52.5u0.525 mL |
4 · Everyday usage
PT-141 (bremelanotide) is the active ingredient in the FDA-approved drug Vyleesi. The figure below is the approved-drug label dose — it is prescription-only and not a recommendation to use a research-chemical vial.
Approved-drug label dose (Vyleesi)
Label-citedVyleesi is taken as needed, at least 45 minutes before anticipated activity.
- Reported amount
- 1.75 mg–1.75 mg≈ 17.5–17.5 units @ 1 mL
- Frequency
- As needed · no more than 1 dose per 24 h
- Cycle
- No more than 8 doses per month (label limit)
FDA prescribing information for Vyleesi (bremelanotide injection), 1.75 mg subcutaneous. PT-141 sold as a research chemical is the same molecule, but Vyleesi is prescription-only — this is the approved-drug dose for reference, not a recommendation to self-administer.
Frequently asked questions
How many insulin units is 1 mg of PT-141 from a 10 mg vial?
- Reconstituting a 10 mg vial with 1 mL of bacteriostatic water gives 10 mg/mL — about 100 mcg per unit. Drawing 1 mg is 0.1 mL, or 10 units on a U-100 insulin syringe. This is measurement math, not a dose recommendation.
How many insulin units is 1.5 mg of PT-141 from a 10 mg vial?
- Reconstituting a 10 mg vial with 1 mL of bacteriostatic water gives 10 mg/mL — about 100 mcg per unit. Drawing 1.5 mg is 0.15 mL, or 15 units on a U-100 insulin syringe. This is measurement math, not a dose recommendation.
Is PT-141 an approved medicine?
- Yes — as the prescription drug Vyleesi (bremelanotide), PT-141 is FDA-approved (2019) for premenopausal women with hypoactive sexual desire disorder. The label dose is 1.75 mg injected under the skin, as needed, with no more than one dose in 24 hours and no more than eight per month. Research-chemical PT-141 is the same molecule but is not a regulated medicine; dosing decisions belong with a licensed clinician.
Why does 3 mL of water push the label dose over one syringe?
- More bacteriostatic water lowers the concentration, so each insulin unit holds less peptide and a fixed dose takes more units. At 3 mL a 5 mg vial is dilute enough that the 1.75 mg label dose needs more than a 100-unit syringe — use less water (the highlighted row) to keep the draw on one syringe.
WikiPeps is a community reference. Reconstitution figures are deterministic measurement math; usage figures are sourced and labeled. Nothing here is medical advice, a recommendation, or an offer to sell peptides — dosing decisions belong with a licensed clinician.